Bone tissue engineering has long been a focal point of research, aiming to address critical large segmental bone defects resulting from severe trauma, tumors, and other bone-related diseases. Despite significant advancements in conventional bone tissue engineering, the simulation of the intricate microenvironment characteristic of natural bone tissue remains inadequate. Natural bone is characterized by intricate macroscopic and microscopic architectures, along with a dynamic microenvironment that facilitates processes such as bone formation, remodeling, and repair. Bone organoids—three-dimensional structures that emulate natural bone tissue derived from stem cells—represent a substantial advancement in both bone tissue engineering and precision medicine. These organoids present a promising pathway for enhancing our understanding of bone biology and disease mechanisms. Their unique potential within precision medicine is underscored by their applications in personalized drug testing, disease modeling, and as platforms for regenerative therapies. As this field continues to progress, bone organoids are poised to play an essential role in developing tailored treatment strategies for disorders related to bones. In this review, we summarize the roles of cell types, biomaterials and culture techniques in the construction of bone organoids, and emphasize the key significance of microenvironment in guiding the maturation of bone organoids. In addition, we will discuss the standardization, current limitations, and future directions of bone organoids to provide insights for research and clinical applications.
Impact Statement
Bone organoids are a major breakthrough in bone tissue engineering, offering accurate models for studying bone biology, diseases, and therapies. This review summarizes their construction, culture techniques, and applications, emphasizing the roles of cell types, biomaterials, and microenvironments in guiding organoid maturation. It also discusses current challenges and future directions, highlighting their potential to advance personalized treatments and improve outcomes in bone repair and regeneration.
ZhaY, LiY, LinT, et al.Progenitor cell-derived exosomes endowed with VEGF plasmids enhance osteogenic induction and vascular remodeling in large segmental bone defects. Theranostics, 2021; 11(1):397–409; doi: 10.7150/thno.50741
2.
JiangW, ZhanY, ZhangY, et al.Synergistic large segmental bone repairby 3D printed bionic scaffolds and engineered ADSC nanovesicles: Towards an optimized regenerative microenvironment. Biomaterials, 2024; 308:122566; doi: 10.1016/j.biomaterials.2024.122566
3.
SchindelerA, McDonaldMM, BokkoP, et al.Bone remodeling during fracture repair: The cellular picture. Semin Cell Dev Biol, 2008; 19(5):459–466; doi: 10.1016/j.semcdb.2008.07.004
4.
KimBC, KwackKH, ChunJ, et al.Comparative transcriptome analysisof human adipose-derived stem cells undergoing osteogenesis in 2D and 3D culture conditions. Int J Mol Sci, 2021; 22(15):7939; doi: 10.3390/ijms22157939
5.
YusteI, LucianoFC, González-BurgosE, et al.Mimicking bone microenvironment: 2D and 3D in vitro models of human osteoblasts. Pharmacol Res, 2021; 169:105626; doi: 10.1016/j.phrs.2021.105626
6.
ChenS, ChenX, GengZ, et al.The horizon of bone organoid: A perspective on construction and application. Bioact Mater, 2022; 18:15–25; doi: 10.1016/j.bioactmat.2022.01.048
7.
ZhaoD, SaidingQ, LiY, et al.Bone organoids: Recent advances and future challenges. Adv Healthc Mater, 2024; 13(5):e2302088; doi: 10.1002/adhm.202302088
8.
IordachescuA, AminHD, RankinSM, et al.An in vitro model for the development of mature bone containing an osteocyte network. Adv Biosys, 2018; 2;2(2); doi: 10.1002/adbi.201700156
9.
LiaoJ, LiX, FanY. Prevention strategies of postoperative adhesion in soft tissues by applying biomaterials: Based on the mechanisms of occurrence and development of adhesions. Bioact Mater, 2023; 26:387–412; doi: 10.1016/j.bioactmat.2023.02.026
10.
BakhshandehB, ZarrintajP, OftadehMO, et al.Tissue engineering; strategies, tissues, and biomaterials. Biotechnol Genet Eng Rev, 2017; 33(2):144–172; doi: 10.1080/02648725.2018.1430464
11.
GuXS. Biodegradable materials and the tissue engineering of nerves. Engineering-Prc, 2021; 7(12):1700–1703; doi: 10.1016/j.eng.2021.10.011
12.
WangJ, ChenX, LiR, et al.Standardization and consensus in the development and application of bone organoids. Theranostics, 2025; 15(2):682–706; doi: 10.7150/thno.105840
13.
KhannaR, KattiKS, KattiDR. Bone nodules on chitosan-polygalacturonic acid-hydroxyapatite nanocomposite films mimic hierarchy of natural bone. Acta Biomater, 2011; 7(3):1173–1183; doi: 10.1016/j.actbio.2010.10.028
14.
ZhangB, LiJ, HeL, et al.Bio-surface coated titanium scaffolds with cancellous bone-like biomimetic structure for enhanced bone tissue regeneration. Acta Biomater, 2020; 114:431–448; doi: 10.1016/j.actbio.2020.07.024
15.
HuiskesR, RuimermanR, van LentheGH, et al.Effects of mechanical forces on maintenance and adaptation of form in trabecular bone. Nature, 2000; 405(6787):704–706; doi: 10.1038/35015116
16.
RobinM, MoulounguiE, Castillo DaliG, et al.Mineralized collagen plywood contributes to bone autograft performance. Nature, 2024; 636(8041):100–107; doi: 10.1038/s41586-024-08208-z
17.
ZimmermannEA, RitchieRO. Bone as a structural material. Adv Healthc Mater, 2015; 4(9):1287–1304; doi: 10.1002/adhm.201500070
18.
YuanG, LinX, LiuY, et al.Skeletal stem cells in bone development, homeostasis, and disease. Protein Cell, 2024; 15(8):559–574; doi: 10.1093/procel/pwae008
19.
KimJM, LinC, StavreZ, et al.Osteoblast-Osteoclast communication and bone homeostasis. Cells, 2020; 9(9):2073; doi: 10.3390/cells9092073
20.
IbáñezL, Nácher-JuanJ, TerencioMC, et al.Osteostatin inhibits M-CSF+RANKL-Induced human osteoclast differentiation by modulating NFATc1. Int J Mol Sci, 2022; 23(15):8551; doi: 10.3390/ijms23158551
21.
KaifuT, MaruhashiT, ChungSH, et al.DCIR suppresses osteoclastic proliferation and resorption by downregulating M-CSF and RANKL signaling. Front Immunol, 2023; 14:1159058; doi: 10.3389/fimmu.2023.1159058
22.
YangY, LiuZ, WuJ, et al.Nrf2 mitigates RANKL and M-CSF induced osteoclast differentiation via ROS-Dependent mechanisms. Antioxidants (Basel), 2023; 12(12):2094; doi: 10.3390/antiox12122094
23.
LiX, HanL, NookaewI, et al.Stimulation of piezo1 by mechanical signals promotes bone anabolism. Elife, 2019; 8:e49631; doi: 10.7554/eLife.49631
24.
KimCH, TakaiE, ZhouH, et al.Trabecular bone response to mechanical and parathyroid hormone stimulation: The role of mechanical microenvironment. J Bone Miner Res, 2003; 18(12):2116–2125; doi: 10.1359/jbmr.2003.18.12.2116
25.
WangJ, WuY, LiG, et al.Engineering large-scale self-mineralizing bone organoids with bone matrix-inspired hydroxyapatite hybrid bioinks. Adv Mater, 2024; 36(30):e2309875; doi: 10.1002/adma.202309875
26.
ZhangJ, GriesbachJ, GaneyevM, et al.Long-term mechanical loading is required for the formation of 3D bioprinted functional osteocyte bone organoids. Biofabrication, 2022; 14(3); doi: 10.1088/1758-5090/ac73b9
27.
WangJ, ZhouD, LiR, et al.Protocol for engineering bone organoids from mesenchymal stem cells. Bioact Mater, 2025; 45:388–400; doi: 10.1016/j.bioactmat.2024.11.017
28.
XieC, LiangR, YeJ, et al.High-efficient engineering of osteo-callus organoids for rapid bone regeneration within one month. Biomaterials, 2022; 288:121741; doi: 10.1016/j.biomaterials.2022.121741
29.
DongW, ChenX, LuoC, et al.Constructing bone organoids based on endochondral ossification model via endogenous enzyme-induced mineralization. Chem Eng J, 2024; 502:157930; doi: 10.1016/j.cej.2024.157930
30.
YangZ, WangB, LiuW, et al.In situ self-assembled organoid for osteochondral tissue regeneration with dual functional units. Bioact Mater, 2023; 27:200–215; doi: 10.1016/j.bioactmat.2023.04.002
31.
LiA, SasakiJI, AbeGL, et al.Vascularization of a bone organoid using dental pulp stem cells. Stem Cells Int, 2023; 2023:5367887; doi: 10.1155/2023/5367887
32.
AmbrosiTH, MarecicO, McArdleA, et al.Aged skeletal stem cells generate an inflammatory degenerative niche. Nature, 2021; 597(7875):256–262; doi: 10.1038/s41586-021-03795-7
33.
NakashimaT, HayashiM, FukunagaT, et al.Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med, 2011; 17(10):1231–1234; doi: 10.1038/nm.2452
34.
BorcianiG, MontalbanoG, BaldiniN, et al.Co-culture systems of osteoblasts and osteoclasts: Simulating in vitro bone remodeling in regenerative approaches. Acta Biomater, 2020; 108:22–45; doi: 10.1016/j.actbio.2020.03.043
35.
ParkY, CheongE, KwakJG, et al.Trabecular bone organoid model for studying the regulation of localized bone remodeling. Sci Adv, 2021; 7(4):eabd6495; doi: 10.1126/sciadv.abd6495
36.
IordachescuA, HughesEAB, JosephS, et al.Trabecular bone organoids: A micron-scale ‘humanised’ prototype designed to study the effects of microgravity and degeneration. NPJ Microgravity, 2021; 7(1):17; doi: 10.1038/s41526-021-00146-8
37.
ZhangW, WangN, YangM, et al.Periosteum and development of the tissue-engineered periosteum for guided bone regeneration. J Orthop Translat, 2022; 33:41–54; doi: 10.1016/j.jot.2022.01.002
38.
Nilsson HallG, MendesLF, GklavaC, et al.Developmentally engineered callus organoid bioassemblies exhibit predictive in vivo long bone healing. Adv Sci (Weinh), 2020; 7(2):1902295; doi: 10.1002/advs.201902295
39.
OkitaK, NakagawaM, HyenjongH, et al.Generation of mouse induced pluripotent stem cells without viral vectors. Science, 2008; 322(5903):949–953; doi: 10.1126/science.1164270
ZhouM, XiJ, ChengY, et al.Reprogrammed mesenchymal stem cells derived from iPSCs promote bone repair in steroid-associated osteonecrosis of the femoral head. Stem Cell Res Ther, 2021; 12(1):175; doi: 10.1186/s13287-021-02249-1
42.
LeeHR, KimS, ShinS, et al.iPSC-Derived MSCs are a distinct entity of MSCs with higher therapeutic potential than their donor-matched parental MSCs. Int J Mol Sci, 2023; 24(1):881; doi: 10.3390/ijms24010881
43.
RajasinghS, SigamaniV, SelvamV, et al.Comparative analysis of human induced pluripotent stem cell-derived mesenchymal stem cells and umbilical cord mesenchymal stem cells. J Cell Mol Med, 2021; 25(18):8904–8919; doi: 10.1111/jcmm.16851
44.
SheynD, Ben-DavidS, ShapiroG, et al.Human induced pluripotent stem cells differentiate into functional mesenchymal stem cells and repair bone defects. Stem Cells Transl Med, 2016; 5(11):1447–1460; doi: 10.5966/sctm.2015-0311
45.
Frenz-WiessnerS, FairleySD, BuserM, et al.Generation of complex bone marrow organoids from human induced pluripotent stem cells. Nat Methods, 2024; 21(5):868–881; doi: 10.1038/s41592-024-02172-2
46.
YinY, ZhouW, ZhuJ, et al.Generation of self-organized neuromusculoskeletal tri-tissue organoids from human pluripotent stem cells. Cell Stem Cell, 2025; 32(1):157–171.e8; doi: 10.1016/j.stem.2024.11.005
47.
CossuG, BirchallM, BrownT, et al.Lancet commission: Stem cells and regenerative medicine [published correction appears in Lancet. Lancet, 2018; 391(10123):883–910; doi: 10.1016/S0140-6736(17)31366-1
48.
JukesJM, BothSK, LeusinkA, et al.Endochondral bone tissue engineering using embryonic stem cells. Proc Natl Acad Sci U S A, 2008; 105(19):6840–6845; doi: 10.1073/pnas.0711662105
49.
MaroltD, CamposIM, BhumiratanaS, et al.Engineering bone tissue from human embryonic stem cells. Proc Natl Acad Sci U S A, 2012; 109(22):8705–8709; doi: 10.1073/pnas.1201830109
50.
Abdul HalimNA, HusseinMZ, KandarMK. Nanomaterials-Upconverted hydroxyapatite for bone tissue engineering and a platform for drug delivery. Int J Nanomedicine, 2021; 16:6477–6496; doi: 10.2147/IJN.S298936
51.
SoleymaniS, NaghibSM. 3D and 4D printing hydroxyapatite-based scaffolds for bone tissue engineering and regeneration. Heliyon, 2023; 9(9):e19363; doi: 10.1016/j.heliyon.2023.e19363
52.
MoX, ZhangD, LiuK, et al.Nano-Hydroxyapatite composite scaffolds loaded with bioactive factors and drugs for bone tissue engineering. Int J Mol Sci, 2023; 24(2):1291; doi: 10.3390/ijms24021291
53.
LiuC, XuM, WangY, et al.Exploring the potential of hydroxyapatite-based materials in biomedicine:A comprehensive review[J]. Materials Science & Engineering R, 2024:161; doi: 10.1016/j.mser.2024.100870
54.
ZiminaA, SenatovF, ChoudharyR, et al.Biocompatibility and physico-chemical properties of highly porous PLA/HA scaffolds for bone reconstruction. Polymers (Basel), 2020; 12(12):2938; doi: 10.3390/polym12122938
55.
LiH, ChenH, DuC, et al.Effect of hydroxyapatite nanowires on formation and bioactivity of osteoblastic cell spheroid. ACS Biomater Sci Eng, 2024; 10(12):7413–7428; doi: 10.1021/acsbiomaterials.4c01159
56.
ZhengR, ZhangN, MaoS, et al.Fast bone regeneration using injectable fully biomimetic organoids with biomineralized and organic microenvironments. Biomater Sci, 2025; 13(2):486–495; doi: 10.1039/d4bm01181c
57.
GigerS, HoferM, Miljkovic-LicinaM, et al.Microarrayed human bone marrow organoids for modeling blood stem cell dynamics. APL Bioeng, 2022; 6(3):36101; doi: 10.1063/5.0092860
58.
FullerJ, LeffertsKS, ShahP, et al.Methodology and characterization of a 3D bone organoid model derived from murine cells. Int J Mol Sci, 2024; 25(8):4225; doi: 10.3390/ijms25084225
59.
MaharjanS, MaC, SinghB, et al.Advanced 3D imaging and organoid bioprinting for biomedical research and therapeutic applications. Adv Drug Deliv Rev, 2024; 208:115237; doi: 10.1016/j.addr.2024.115237
60.
DaiK, ZhangQ, DengS, et al.A BMP-2-triggered in vivo osteo-organoid for cell therapy. Sci Adv, 2023; 9(1):eadd1541; doi: 10.1126/sciadv.add1541
61.
ToniR, BarbaroF, Di ConzaG, et al.A bioartificial and vasculomorphic bone matrix-based organoid mimicking microanatomy of flat and short bones. J Biomed Mater Res B Appl Biomater, 2024; 112(1):e35329; doi: 10.1002/jbm.b.35329
62.
WuL, XuT, LiS, et al.Sequential activation of osteogenic microenvironment via composite peptide-modified microfluidic microspheres for promoting bone regeneration. Biomaterials, 2025; 316:122974; doi: 10.1016/j.biomaterials.2024.122974
63.
ChenC, LiZ, XuC, et al.Self-Assembled nanocomposite hydrogels as carriers for demineralized bone matrix particles and enhanced bone repair. Adv Healthc Mater, 2024; 13(10):e2303592; doi: 10.1002/adhm.202303592
64.
WangY, HuangYC, GertzmanAA, et al.Endogenous regeneration of critical-size chondral defects in immunocompromised rat xiphoid cartilage using decellularized human bone matrix scaffolds. Tissue Eng Part A, 2012; 18(21–22):2332–2342; doi: 10.1089/ten.TEA.2011.0688
65.
SchwartzZ, HyzySL, MooreMA, et al.Osteoinductivity of demineralized bone matrix is independent of donor bisphosphonate use. J Bone Joint Surg Am, 2011; 93(24):2278–2286; doi: 10.2106/JBJS.J.01469
66.
KirkJF, RitterG, WatersC, et al.Osteoconductivity and osteoinductivity of NanoFUSE(®) DBM. Cell Tissue Bank, 2013; 14(1):33–44; doi: 10.1007/s10561-012-9297-1
67.
KangHJ, ParkSS, TripathiG, et al.Injectable demineralized bone matrix particles and their hydrogel bone grafts loaded with β-tricalcium phosphate powder and granules: A comparative study. Mater Today Bio, 2022; 16:100422; doi: 10.1016/j.mtbio.2022.100422
68.
GruskinE, DollBA, FutrellFW, et al.Demineralized bone matrix in bone repair: History and use. Adv Drug Deliv Rev, 2012; 64(12):1063–1077; doi: 10.1016/j.addr.2012.06.008
69.
HuY, HouZ, LiuZ, et al.Oyster mantle-derived exosomes alleviate osteoporosis by regulating bone homeostasis. Biomaterials, 2024; 311:122648; doi: 10.1016/j.biomaterials.2024.122648
70.
WangX, FangJ, ZhuW, et al.Bioinspired highly anisotropic, ultrastrong and stiff, and osteoconductive mineralized wood hydrogel composites for bone repair. Adv Funct Materials, 2021; 31(20):2101068; doi: 10.1002/adfm.202010068
71.
LiS, YangY, YuB, et al.A novel deer antler-inspired bone graft triggers rapid bone regeneration. Adv Mater, 2025; 37(6):e2411571; doi: 10.1002/adma.202411571
72.
WongSK, YeeMMF, ChinKY, et al.A review of the application of natural and synthetic scaffolds in bone regeneration. J Funct Biomater, 2023; 14(5):286; doi: 10.3390/jfb14050286
73.
GehlenJ, QiuW, SchädliGN, et al.Tomographic volumetric bioprinting of heterocellular bone-like tissues in seconds. Acta Biomater, 2023; 156:49–60; doi: 10.1016/j.actbio.2022.06.020
74.
BukhariMMM, KhabooshaniM, NaqviSM, et al.Estrogen deficiency alters vascularization and mineralization dynamics: Insight from a novel 3-D humanized and vascularized bone organoid model. Am J Physiol Cell Physiol, 2025; 328(3):C743–C756; doi: 10.1152/ajpcell.00738.2024
75.
LiuJ, WangQ, LeY, et al.3D-Bioprinting for precision microtissue engineering: Advances, applications, and prospects. Adv Healthc Mater, 2025; 14(10):e2403781; doi: 10.1002/adhm.202403781
76.
WangZ, XiangL, LinF, et al.3D bioprinting of emulating homeostasis regulation for regenerative medicine applications. J Control Release, 2023; 353:147–165; doi: 10.1016/j.jconrel.2022.11.035
77.
MurphySV, De CoppiP, AtalaA. Opportunities and challenges of translational 3D bioprinting. Nat Biomed Eng, 2020; 4(4):370–380; doi: 10.1038/s41551-019-0471-7
78.
ZhangY, LiD, LiuY, et al.3D-bioprinted anisotropic bicellular living hydrogels boost osteochondral regeneration via reconstruction of cartilage-bone interface. Innovation (Camb), 2024; 5(1):100542; doi: 10.1016/j.xinn.2023.100542
79.
MansoorifarA, GordonR, BerganR, et al.Bone-on-a-chip: Microfluidic technologies and microphysiologic models of bone tissue. Adv Funct Mater, 2021; 31(6):2006796; doi: 10.1002/adfm.202006796
80.
KimMK, PaekK, WooSM, et al.Bone-on-a-Chip: Biomimetic models based on microfluidic technologies for biomedical applications. ACS Biomater Sci Eng, 2023; 9(6):3058–3073; doi: 10.1021/acsbiomaterials.3c00066
81.
LeeS, KimYG, JungHI, et al.Bone-on-a-chip simulating bone metastasis in osteoporosis. Biofabrication, 2024; 16(4); doi: 10.1088/1758-5090/ad6cf9
82.
NiuX, LiN, DuZ, et al.Integrated gradient tissue-engineered osteochondral scaffolds: Challenges, current efforts and future perspectives. Bioact Mater, 2023; 20:574–597; doi: 10.1016/j.bioactmat.2022.06.011
83.
ZhangY, YuT, DingJ, et al.Bone-on-a-chip platforms and integrated biosensors: Towards advanced in vitro bone models with real-time biosensing. Biosens Bioelectron, 2023; 219:114798; doi: 10.1016/j.bios.2022.114798
84.
NetoE, MonteiroAC, Leite PereiraC, et al.Micropathological chip modeling the neurovascular unit response to inflammatory bone condition. Adv Healthc Mater, 2022; 11(11):e2102305; doi: 10.1002/adhm.202102305
85.
RenK, LiE, AydemirI, et al.Development of iPSC-derived human bone marrow organoid for autonomous hematopoiesis and patient-derived HSPC engraftment. Blood Adv, 2025; 9(1):54–65; doi: 10.1182/bloodadvances.2024013361
86.
LiR, WangJ, LinQ, et al.Mechano-Responsive biomaterials for bone organoid construction. Adv Healthc Mater, 2025; 14(6):e2404345; doi: 10.1002/adhm.202404345
87.
WuX, HuY, ShengS, et al.DNA-based hydrogels for bone regeneration: A promising tool for bone organoids. Mater Today Bio, 2025; 31:101502; doi: 10.1016/j.mtbio.2025.101502
88.
GaiTT, ZhangH, HuY, et al.Sequential construction of vascularized and mineralized bone organoids using engineered ECM-DNA-CPO-based bionic matrix for efficient bone regeneration. Bioact Mater, 2025; 49:362–377; doi: 10.1016/j.bioactmat.2025.02.033
89.
ZhuM, ZhangH, ZhouQ, et al.Dynamic GelMA/DNA dual-network hydrogels promote woven bone organoid formation and enhance bone regeneration. Adv Mater, 2025; 37(24):e2501254; doi: 10.1002/adma.202501254
90.
ShuaiY, YangT, ZhengM, et al.Oriented cortical-bone-like silk protein lamellae effectively repair large segmental bone defects in pigs. Adv Mater, 2025; 37(10):e2414543; doi: 10.1002/adma.202414543
